Skip to main content

Kodiak Sciences Inc.

For the period ended Mar 31, 2025. Filed May 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

March 31,2025December 31,2024
Assets
Current assets:
Cash and cash equivalents$138,851$168,074
Prepaid expenses and other current assets3,8343,862
Total current assets142,685171,936
Restricted cash6,1846,184
Property and equipment, net97,903102,222
Operating lease right-of-use asset42,47346,508
Other assets8,6648,728
Total assets$297,909$335,578
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$6,543$3,915
Accrued and other current liabilities13,38511,030
Operating lease liability10,94810,628
Total current liabilities30,87625,573
Operating lease liability, net of current portion56,69159,717
Liability related to sale of future royalties100,000100,000
Long-term deposit1,500—
Total liabilities189,067185,290
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively——
Common stock, $0.0001 par value, 490,000,000 shares authorized at March 31, 2025 and December 31, 2024; 52,751,875 and 52,726,916 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively55
Additional paid-in capital1,495,0361,479,021
Accumulated deficit(1,386,199)(1,328,738)
Total stockholders’ equity108,842150,288
Total liabilities and stockholders’ equity$297,909$335,578
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.